McPherson’s (ASX MCP) is a Leading Beauty and Wellness Retailer

A'Kin

Henry Fung

Henry is a co-founder of MF & Co. Asset Management with over 19 years of experience as a trader, investor and asset manager. Henry is the instructor of the Professional Trading Course, which is a free 5-day course on how to become a profitable trader.

September 10, 2019

Please note that any research that we publish does not take timing into consideration. We may publish research for a stock that we believe is of good quality but not necessarily trading at a discount or at a technical level for a high probability entry. If you would like to maximise your returns with optimised entry, exit and stop loss levels, check out our High Conviction Report with a $1, 30 day trial.

Today, we will look at why we like McPherson’s.

McPherson’s is a leading beauty and wellness retailer which has recently refocused its strategy on its core brands.

Along with that, the company has managed to stem revenue decline and at the same time, grew profits two years in a row.

We first became interested in this stock and recommended it to our clients around July, when the stock was $1.70.

Since then, the company reported very positive FY19 numbers and the stock has rallied to over $2.20.

We think McPherson’s continues to have potential in the long term and this is why we like MCP.

About McPherson’s Limited (ASX MCP)

Founded in 1860, McPherson’s Limited (ASX MCP)is a leading supplier of health, wellness, beauty, household, and personal care products in Australasia, with operations in Australia, New Zealand, and Asia. The company also manages some significant brands for overseas agency partners such as Dr. Wolff and Karen Murrell.

The major revenues of the company are from its diversified portfolio of owned market-leading brands, including Manicare, Lady Jayne, Dr. LeWinn’s, A’kin, Glam by Manicare, Swisspers, Moosehead, Maseur&Multix.

McPherson’s mission is to provide superior and comprehensive products that customers need in their everyday lives. Also, the company strives to provide consumers with products that offer exceptional value in terms of both price and quality.

Strategy Overview

McPherson’s plans to grow in health, wellness, and beauty via a revamped three-pronged execution strategy by investing and delivering growth in its six core-owned brands, establishing strategic customer and supplier partnerships, and driving growth across geographies.

You may also like...
Xero Ltd (ASX:XRO): Strong Growth from a Non-Discretionary Product

With the tailwind from the strong sales growth of the group’s major skincare brand, Dr. LeWinn’s and A’kin (+42% combined), the company arrested the decline in its revenue.

FY19 sales were level with FY18 ($210 million and $211 million respectively). The company delivered a 17% growth in underlying profit before tax.

Industry Analysis

The cosmetics and wholesale toiletry industry in Australia are projected to grow at an annualized rate of 2.4% over the next five years, to $8.6 billion.

McPherson Limited ASX MCP Industry revenue
Source: IbisWorld

An aging population, the development of new multi-functional products, and increasing awareness of health and wellbeing are all likely to stimulate growth in the industry over the next five years.

Despite being in the mature phase of its life cycle, the Australian beauty and wellness industry is continuing to evolve in step with global trends.

However, competition from international online retailers that offer similar products at large discounts has limited profit margins of luxury cosmetics wholesalers.

The competition is increasing pressure on the supply chain of the domestic industry and could further constrict its profit margins in the future.

Increasing demand for Dr. LeWinn’s China

During FY19, the company achieved 125% year on year growth in sales of its Dr.LeWinn’s brand.

This growth was driven by strong domestic demand and a significant increase in export sales, particularly in China through ABM, the company’s strategic and exclusive partner for that country.

The Dr.LeWinn’s line has gained a reputation in China for superior quality and affordable pricing.

Reviews have been favourable for the Line Smoothing Complex Triple Action Day Defence, an innovative anti-aging day treatment containing powerful anti-oxidants that defends against all known free radicals responsible for premature aging.

You may also like...
Alumina (ASX:AWC) - Quality At An Oversold Price

Dr. LeWinn’s brand has grown from $1 million in FY17 to $3 million in FY18 and $16 million in FY19 enabled by manufacturing step change investment and partnership with Aware Group.

The strong growth shows that the strategy of growing its China-facing business has paid off in spades for the company.

Successful business strategy

McPherson’s recent business strategy refocuses the business purely on health, wellness, and beauty, and revitalizing its owned brands in these markets.

The company accordingly restructured its core portfolio to fit the target market and improved market presence with above-the-line marketing.

The new strategy led to a 13% growth in sales revenue from the core six brands in FY19, compared to 6% in FY18.

Market competition risk

The beauty industry has changed under the influence of digital trends and social media platforms. When exposed to more information about new products, potential customers become aware of their choices.

On the flip side, this growing trend makes it easier for customers to shop online.

International online retailers that offer similar products at large discounts have increased competition in the industry.

Financial Performance and Peer Comparison

McPherson’s performance

McPherson Limited ASX MCP -Performance Trend

McPherson's (ASX MCP) - Revenue

McPherson's (ASX MCP) - Gross Profit

McPherson's (ASX MCP) - Net Income

McPherson's (ASX MCP) - EBITDA

The company is facing declining revenues. Sales revenue in 2019 was $211.34 million, down from $349.01 million in 2015, a decline of an average 11.33% per annum.

However, revenue remained flat between FY2018 and FY2019 primarily due to a pick-up in revenues from the company’s owned brands.

EBITDA and net income have been erratic during the period, falling sharply in 2017.

However, the company is experiencing a strong uptrend in its net profits primarily due to its new strategy.

You may also like...
Xero Ltd (ASX:XRO): Strong Growth from a Non-Discretionary Product

With the refocus of the company on its core products, revenue should start to tick up and net profits should continue to rise.

Comparison with peers

McPherson Limited ASX MCP-COMPARISON with peers

The other major players in this industry are L’Oreal Australian Pty Ltd and Unilever Australia Pty Ltd, both having market shares in the range of 6-8%.

In comparison, McPherson’s has an estimated market share of just 2-3%.

During FY17, L’Oreal had higher revenue growth of 4.3% compared to a revenue decline of 10.60% for McPherson’s, and a higher EBITDA margin of 18.95% versus 1.56%.

During the same period, compared to Unilever’s gross profit margin of 30.09%, McPherson’s had a higher gross profit margin of 42.71%.

Even though McPherson’s numbers in the past are somewhat inferior to those of its competitors, the strong profit margins would help to improve the company’s overall profitability once revenues grow as per the new strategy.

Strong upside potential with strategy refocus

McPherson’s business strategy of refocusing on its core owned brands has gained traction, as shown by the positive results in FY19.

Dr. LeWinn’s, one of the company’s core brands, has shown growth in revenue and market acceptance.

The company has arrested the decline in revenues and is now seeing a strong uptick in profits. This should further grow with its new strategy focusing on its six core-owned brands.

The economic environment indicates that the industry will continue to grow, given demographic factors and digital trends.

Although digital and social media would increase the competition from online in the industry, it would also lead to enhanced opportunities in the global market.

The MCP share price looks to have strong upside potential as the company continues to grow profits with its strategy refocus.

Are you looking for more stocks to buy? In our opinion, buying the right stock at the right time is just half the battle – knowing how to manage the position and risk is just as, if not more important. Take our free 5-day trade like a professional course, it give you the foundational knowledge required to become a profitable trader.

This is general advice only. MF & Co Asset Management has not considered your personal financial needs, objectives or current situation. This information is not an offer, solicitation, or a recommendation for any financial product unless expressly stated. You should seek professional investment advice before making any investment decision.

You May Also Like…

Subscribe

Want more Free Research?

Subscribe today for free and get an alert when we have new research and webinars.

Invalid email address
We promise not to spam you. You can unsubscribe at any time.

Testimonials

What People are Saying...

See what people are saying about our research, products and services.

Timely advice, very informative and well researched.Very positive from a share trading view.
Brendon Beattie
Brendon Beattie
1651450498
Nice reporting, thank you
useful
Exceptional information that is concise and insightful. Keep up the great work !!!
BRIAN MINOTTO
BRIAN MINOTTO
1629364744
I feel MF and Co are very informative with their advice and recommendations.
Norman Wilkins
Norman Wilkins
1629360008
Good service with frequent emailed share suggestions.
Peter Farrell
Peter Farrell
1629344394
Even I never trade with MF&Co, I watch all of Henry's review and analysis, very impressed with the accuracy and... objective of those thoughts.Of course no one can say what the future will be, but at least when reading those reviews, we know where we are, then sometimes that is the best thing that you can wish for.read more
Vu Nguyen
Vu Nguyen
1629071090
Excellent service, not pushy, clear reporting highly recommended
Luke Stewart
Luke Stewart
1629069957
Some very useful research
Richard Goodwin
Richard Goodwin
1628829227
I very much appreciate the profound stock market research and the peceived honesty.
Easy to understand research for “dummies guide to shares trading”
Graham Ko
Graham Ko
1628523052
js_loader

MF & Co. Asset Management

MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.

We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.

Contact

Get In Touch

Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm

Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000

 

Share This